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INTRODUCTION 
Piroxicam is a potent anti-inflammatory drug. It is used 
in treatment of osteoarthritis, rheumatoid arthritis, 
ankylosing spondylitis and acute gout disease1.It has 
prolonged half life of about 45hrs2.It is poorly water 
soluble drug and when administered orally it may cause 
bioavailability problems due to its poor solubility and 
dissolution rates in biological fluids3. Hence the present 
work was aimed at increasing the rate of dissolution of 
Piroxicam thus providing faster rate of absorption by 
adding potential superdisintegrants like isapghula, 
Crobitter taste of Piroxicam, and aspartame was used as 
sweetening agent. Nine formulations of fast dissolving 
tablets of Piroxicam using three superdisintegrants 
namely isaphgula (4%, 5% and 6%), fenugreek (4%, 5% 
and 6%) and guar gum (4%, 5% and 6%) and a control 
formulation (without superdisintegrant) were prepared by 
direct compression method isaphgula and fenugreek in 
different concentrations4 . 
MATERIALS AND METHODS 
Piroxicam was procured from XL Pharmaceuticals Ltd, 
Rajasthan, India. Microcrystalline 
Cellulose, and Aspartame, Mannitol, Magnesium 
stearate, were procured from CDH, New-Delhi India. 
Preparations of Piroxicam fast dissolving tablets 
Piroxicam fast dissolving tablets were prepared by direct 
compression method according to the formula given in 
Table no-1. A total of nine formulations (F1toF9) of 
Piroxicam fast dissolving tablets were prepared using 
three superdisintegrants namely isapghula, fenugreek and 
guar gum with three different concentrations (4%, 5% 
and 6%). A control tablet was also prepared without any 
superdisintegrant (F10). 
All the ingredients were passed through mesh no. 60 
separately and collected. The drug, mannitol and 
microcrystalline cellulose were mixed uniformly with 
gentle trituration using mortar and pestle to get a uniform 
mixture. Required quantity of superdisintegrant and 
aspartame were taken for each specified formulation and 
mixed with the above mixture. Finally magnesium 
stearate were added and mixed well. The mixed blend of 
drug and excipients were compressed using 7 mm punch 
on 10 stations “B” Tooling Rotatory Tablet Punching 
Machine to produce convex faced tablets, weighing 200 
mg each (Table-1). Before tablet preparation, the mixture 
blend of all the formulations were subjected to 
compatibility studies (IR) and Precompression 
parameters like Angle of repose, bulk density, tapped 
density, compressibility index and hausner‟s ratio. 
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ABSTRACT 
The demand for fast dissolving tablets has been growing during the last decade, especially for geriatric and pediatric patients 
who have swallowing rapidly. Piroxicam is a potent anti-inflammatory drug used in treatment of osteoarthritis, rheumatoid 
arthritis, ankylosing Spondylitis and acute gout disease. In the present work, 9 formulations of fast dissolving Tablets of 
Piroxicam (F1 to F9) were prepared using three different Superdisintegrants namely isapghula, fenugreek and guar gum with 
three concentrations (4%, 5% and 6%) and a control F10 (without superdisintegrant) by direct compression method. The final 
blend of the drug and excipients were evaluated for powder flow properties, bulk density, tapped density, compressibility index 
and hausner‟s ratio. All the formulations were evaluated for thickness, weight variation, disintegration time, hardness, 
friability. Formulation F7 showed the lowest disintegration time. In-vitro dissolution studies revealed that formulation F4 
showed 99.18 % percent drug release at the end of 60 minutes. 
Keywords: Anti-inflammatory, Direct compression, fast dissolving, Piroxicam,      Superdisintegrant 
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Table 1: Formulation of Piroxicam Fast dispersible Tablets . 
S.No Compositon(mg) F1 F2 F3 F4 F5 F6  F7 F8 F9 F10 
1 Piroxicam 20 20 20 20 20 20 20 20 20 20 
2 Isapghula 8 10 12 - - - - - - - 
3 Fenugreek - - - 8 10 12 - - - - 
4 Guar gum - - - - - - 8 10 12 - 
5 Microcrystalline 
cellulose 
104 102 100 104 102 100 104 102 100 112 
6 Mannitol 58 58 58 58 58 58 58 58 58 58 
7 Aspartame 8 8 8 8 8 8 8 8 8 8 
8 Magnesium stearate 2 2 2 2 2 2 2 2 2 2 
 Total Weight(mg) 200 200 200 200 200 200 200 200 200 200 
                 FA1, FA2, FA3- Isapghula (4%, 5% and 6%). 
                    FA4, FA5, FA6- fenugreek (4%, 5% and 6%). 
                    FA7, FA8, FA9- Guar Gum (4%, 5% and 6%). 
                    F10-Control (without Superdisintegrants). 
 
Evaluation of powder blend 
Angle of repose: 
The angle of repose of powder blend was determined by 
the funnel method. The accurately 
Weighed powder blend were taken in funnel. The height 
of the funnel was adjusted in such a way that the tip of 
the funnel just touches the heap of the powder blend. The 
powder blend was allowed to flow through the funnel 
freely onto the surface 5 .The diameter of the powder 
cone was measured and angle of repose was calculated 
using the following equation 
θ= tan -1 (h/r) 
   Where „h‟ and „r‟ are the height and radius of the cone 
Bulk Density: 
Bulk density Pb is defined as the mass of the powder 
divided by the bulk volume and is expressed as g/cm3. 
Weighed quantity of powder blend from each 
formulation was taken in a measuring cylinder and the 
initial volume of the powder blend (Vb) in the measuring 
cylinder was noted 6. This was calculated by using the 
formula 
Pb = M / Vb 
Where, Pb - Bulk density, M - Weight of the sample in g, 
Vb- volume of the blend in cm3 
Tapped Density: 
It is the ratio of total mass of the powder to the tapped 
volume of powder. The volume was measured by tapping 
the powder blend for 50 times. Then the tapping was 
done for 50 times and the tapped volume was noted. 
Tapped density was calculated by using the following 
formula 
Pt= M / Vt 
Where, Pt-Tapped density, M - Weight of the sample in 
g, Vt - Tapped volume of blend in cm3. 
Compressibility index and hausners ratio: 
The compressibility index of the powder blend was 
determined by Carr‟s compressibility index and the 
Hausners ratio is calculated by using the formula 7 
Hausner‟sRatio = Tapped density / Bulk density 
Carr‟s index (%) = [(TBD-LBD) x 100] / TBD 
TBD = Total bulk density, LBD = Loose bulk density 
IR Spectral Analysis: 
It was used to study the interactions between the drug 
and the excipients. The FT-IR method was used for 
preparation of sample and spectra were recorded over the 
wave number 4000 to 400cm in a BRUKUR- FT-ir 
spectrophotometer. IR spectral studies of Pure 
Piroxicam, Superdisintegrants and Piroxicam containing 
highest proportion of individual superdisintegrant were 
carried out. 
Evaluations of tablets 
Weight Variation: 
Twenty tablets were randomly selected and individually 
weighed 8. The average weight of tablets was calculated. 
Then the individual weight was compared with that of 
average weight. 
Hardness: 
The tablets to be tested are held between a fixed and a 
moving jaw of hardness test apparatus (Monsanto) and 
reading of the indicator is adjusted to zero 9. The screw 
knob was moved forward until the tablet breaks and the 
force required breaking the tablet was noted. 
Friability: 
Friability test was performed using Roche friabilator. 
Ten tablets were weighed and placed in the friabilator, 
which was then operated for 25 revolutions per minute 10. 
After 100 revolutions the tablets were dusted and 
reweighed. The percentage friability was determined 
using the formula, 
Percentage friability = Initial weight - Final weight × 100    
                     Initial weight 
In-Vitro disintegration time: 
The test was carried out in a disintegration apparatus 
using distilled water as disintegration medium (at 370 C 
± 0.50 C). A tablet was placed in each of six tubes of the 
apparatus and one disc was added to each tube 11. The 
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time taken for complete disintegration of the tablet with 
no mass remaining in the apparatus was measured in 
seconds. 
In-vitro dissolution test:  
Dissolution test can be carried in 0.1N HCl (ph-1.2). The 
USP 2 Paddle apparatus at 50 rpm is suitable for 
dissolution testing. Dissolution medium taking 900 ml. 
Sample is taken from the medium and measure the drug 
content in U.V. spectrophotometer 12-13. 
 
Table 2: Evaluation of powder blend 
Formulation code Angle of 
repose* 
Bulk density 
(gm/cm3)* 
Tapped density 
(gm/cm3)* 
Compressibility 
Index (%)* 
Hausner’s 
ratio* 
F1 32.63±1.42 0.57±.005 0.79±.011 14.71±1.67 1.30±.034 
F2 34.52±1.36 0.59±.026 0.79±.030 15.32±1.15 1.34±.005 
F3 31.72±1.52 0.52±.025 0.71±.060 14.26±1.49 1.29±.096 
F4 29.08±1.14 0.40±.066 0.56±.060 15.07±1.42 1.26±.011 
F5 28.13±1.02 0.38±.086 0.53±.085 13.17±1.20 1.31±.102 
F6 29.14±1.08 0.43±.005 0.61±.045 14.83±1.91 1.28±.121 
F7 32.11±1.15 0.42±.060 0.59±.059 14.75 ±1.54 1.32±.062 
F8 30.14±1.34 0.44±.041 0.59±.025 15.24±1.31 1.33±.075 
F9 29.81±1.32 0.47±.026 0.67±.017 13.83±1.32 1.32±.080 
F10 29.81±1.21 0.46±.040 0.65±.017 15.76±1.88 1.34±.073 
 
Table 3: Evaluation of Fast Dissolving Tablet of Piroxicam 
Batch 
code 
Weight variation 
(mg) 
Thickness 
(mm) 
Hardness 
(kg/cm
2
) 
Friability 
(%) 
Disintegration time 
(sec) 
F1 200±1.2 3.59±.08 2.8±0.231 .62±0.183 30±0.41 
F2 200±1.3 3.47±.03 2.7±0.234 .57±0.235 31±0.25 
F3 201±1.3 3.66±.14 2.5±0.254 .65±0.521 34±0.43 
F4 200±1.1 3.62±.23 2.9±0.278 .84±0.542 32±0.22 
F5 202±1.4 3.74±.26 2.7±0.143 .78±0.345 29±0.36 
F6 199±1.2 3.48±.42 2.8±0.352 .76±0.374 30±0.52 
F7 201±1.3 3.82±.53 3.0±0.231 .45±0.245 28±0.32 
F8 200±1.2 3.86±.27 2.7±0.324 .54±0.613 38±0.43 
F9 200±1.1 3.31±.75 3.1±0.341 .48±0.363 35±0.23 
F10 200±1.5 3.42±.81 3.2±0.256 .64±0.554 110±1.54 
 
Table 4: in-vitro dissolution test 
Time    
(in min)  
% Cumulative release of drug from FDT 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
0 0 0 0 0 0 0 0 0 0 0 
10 57 56 69.4 70.38 64.12 66.89 65.67 63.64 73.82 23.65 
20 65.12 75.13 74.43 78.8 70.31 70.25 71.21 69.71 79.04 29.98 
30 78.67 80.61 81.9 85.29 78.21 75.31 75.51 76.80 81.58 34.32 
40 83 87.55 88.9 84.88 81.78 81.48 82.79 83.22 86.22 43.02 
50 92.49 94.16 89.91 93.58 90.32 88.42 87.39 92.65 90.64 49.45 
60 98.14 96.68 94.27 99.18 96.36 98.26 99.13 98.65 97.35 56.18 
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Release curve of FDT: 
 
Figure 1: release curve with isapghula 4%, 5%, 6%. 
 
Figure 2: release curve with fenugreek 4%, 5%, 6%. 
 
 
Figure 3: release curve with guar gum 4%, 5%, 6% and withought superdisintrigrants 
 
FT-IR Spectra:  
PIROXICAM: FT-IR 
 
Figure 4: FT-IR of Piroxicam 
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Table 5: FT-IR interpetation Spectra of piroxicam 
Frequency(cm-1) Assignment 
3654 O-H Stretch 
2361 C-H 
1430 C-H  Bend 
1141 C-H Out of plane bend 
 
RESULTS AND DISCUSSION: 
It has been observed that Bulk density and tapped density 
of powder blend evaluated. The angle of repose for the 
entire formulations blend was found to be in the 
range28.13 to 34.63°. Formulations with Isapghula (F1-
F3) as a disintegrant showed angle of repose values ≤ 
30o. Whereas formulation fenugreek containing (F4-F6) 
was showed angle of repose values > 30o, Guar gum (F7-
F9) was showed angle of repose values ≤30o indicating 
only fair flow property of the powder blend. 
Compressibility index was found to be in the range 13.61 
% to 15.76 %. All formulations showed good flow 
properties. Hausner‟s ratio was found to be in the range 
1.26 to 1.34and that indicated that all formulation has 
good flow properties. The batches F3, showed low 
hardness and F10 higher (2.5-3.2kg/cm2). Higher 
friability F4 and low friability F7 (0.84- 0.45%).all 
parameters show weight variation, thickness, 
Disintegration time (sec) within standard limit. All 
formulation was subjected to dissolution. From all the 
above observations it was concluded that the  
formulation F9 containg guar gum 6% found to be better 
formulation in terms of rapid dissolution (73.82 ) and but 
maximum percentage drug release was found 99.18 of 
formulation F4, with fenugreek 4%. 
CONCLUSION: 
It can be concluded from the whole study that fast 
dissolving tablets of Piroxicam drug. Natural 
Superdisintegrants can be used as pharmaceutical 
excipients for oral drug delivery.So natural 
superdisintegrant like fenugreek exhibited faster drug 
dissolution will lead to improve bioavailability, effective 
therapy, improve patient compliance, and satisfies all the 
criteria as fast dissolving tablet. It was concluded 
formulation f4 maximum percentage drug release was 
found 99.18, with fenugreek 4%. 
ACKNOWLEDGEMENT: 
Authors are highly thankful to the Department of 
Pharmacy, School of Medical Allied Sciences, Galgotias 
University, and Greater Noida India for providing library 
facility during literature survey. 
 
REFERENCES 
1. Martindale-Extra Pharmacopoeia, the Pharmaceutical 
Preparations, London, 1982, 28,276. 
2. Satoskar RS, Bhandarkar SD, Pharmacology and 
Pharmacotherapeutics, Popular prakasan Pvt Ltd, Mumbai, 
1988, 21,173. 
3. Shukla V, Rajashree MS, Bolmal UB and Manvi FV. The 
Indian Pharmacist, 2007, 6,685-688. 
4. Bhagawati ST, Hiremath SN, Sreenivas SA. Indian J. Pharm. 
Educ. Res, 2005; 39, 194-197. 
5. Akihiko I, Masayasu S. Development of oral dosage form for 
elderly patient: use of agar as base of rapidly disintegrating 
oral tablets. Chem Pharm Bull 2005; 44 suppl 11:2132-36. 
6. Carr R.L. Evaluating Flow Properties of Solids. Chem. Eng 
1965; 72:163–168.  
7. Shah D, Shah Y. and Rampradhan M. Development and 
evaluation of controlled release Diltiazem hydrochloride 
micro particulates using cross linked poly vinyl alcohol. Drug 
Dev.Ind.Pharm 1977; 23:567-574. 
8. Leon Lachman., Herbert A., Liberman. And Joseph L., 
Kamig. The Theory and Practice of Industrial Pharmacy – 
Tablets. Mumbai: Varghese Publishing House; 1991. p. 
318,370,300. 
9. Rippie, E. Compression of solids and compressed dosage 
forms. In: Encyclopedia of Pharmaceutical Technology. 
Swarbrick J. Marcel Dekker Inc 1990; 3:149-166. 
10. Chowdary K.P.R., and Hymavathy.R. Formulation and 
dissolution rates studies on dispersible tablets of Ibuprofen. 
Indian. J. Pharm.Sci 2000; 62:213-216. 
11. Mishra DN, Bindal M, Singh SK, Kumar SGV. Indian 
J.Pharm. Sci, 2005, 67, 685-687. 
12. Vijaya, K.S.G, and Mishra, D.N. Rapidly Disintegrating Oral 
Tablets of Meloxicam. Indian Drugs 2006; 43:117-121. 
13. James Klancke. Dissolution Testing of Orally Disintegrating 
Tablets. Dissolution Technologies 2003; 6:6-8. 
 
 
 
 
 
 
 
 
 
 
 
